Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, December 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
High Throughput Screening of Novel Protein Therapeutics
Tuesday, July 15, 2014
INTEGRA VIAFLO 96 - a handheld 96-channel electronic pipette.

New Magnetic Technology for Bioseparations and Studies of Biomolecular Interactions
Tuesday, July 15, 2014
AMSBIO announces MagSi-Direct - a revolutionary technology that brings the power, simplicity, and convenience of magnetic separation.

PerkinElmer Launches LabChip® GX and GXII Touch™ Systems
Thursday, July 10, 2014
New automated platform provides life sciences researchers with precise nucleic acid quantification and protein characterization.

Zetasizer Helix Combines Dynamic Light Scattering and Raman Spectroscopy for Advanced Protein Structure Analysis
Tuesday, July 08, 2014
The new Zetasizer Helix from Malvern Instruments is a powerful tool for early stage biopharmaceutical development that enables the detailed study of mechanisms of protein aggregation.

Method Separates Oxidized Monoclonal Antibody (MAb) Species
Friday, July 04, 2014
Thermo Scientific™ ProPac™ HIC-10 column used to separate the papain fragments.

Mettler-Toledo’s Next Generation Checkweighers
Thursday, July 03, 2014
Deliver unparalleled weighing accuracy with high throughput.

Olink Bioscience Introduces a 92-protein Biomarker Panel
Wednesday, July 02, 2014
Proseek® Multiplex Inflammation I 96x96 for inflammatory diseases.

DynaPro® Plate Reader Optimizes Screening Process for Biotherapeutic Candidates
Wednesday, July 02, 2014
The high-throughput DynaPro Plate Reader utilizes dynamic light scattering to identify most promising mAb buffer conditions prior to extended stability testing.

Mettler-Toledo Safeline X-ray’s X36 Series Boosts Versatility
Saturday, June 28, 2014
Five times more sensitive to x-rays than traditional systems for enhanced quality control.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 493
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn